517 related articles for article (PubMed ID: 32849529)
1. PDLIM7 Synergizes With PDLIM2 and p62/Sqstm1 to Inhibit Inflammatory Signaling by Promoting Degradation of the p65 Subunit of NF-κB.
Jodo A; Shibazaki A; Onuma A; Kaisho T; Tanaka T
Front Immunol; 2020; 11():1559. PubMed ID: 32849529
[TBL] [Abstract][Full Text] [Related]
2. MKRN2 is a novel ubiquitin E3 ligase for the p65 subunit of NF-κB and negatively regulates inflammatory responses.
Shin C; Ito Y; Ichikawa S; Tokunaga M; Sakata-Sogawa K; Tanaka T
Sci Rep; 2017 Apr; 7():46097. PubMed ID: 28378844
[TBL] [Abstract][Full Text] [Related]
3. HSP70 mediates degradation of the p65 subunit of nuclear factor κB to inhibit inflammatory signaling.
Tanaka T; Shibazaki A; Ono R; Kaisho T
Sci Signal; 2014 Dec; 7(356):ra119. PubMed ID: 25515536
[TBL] [Abstract][Full Text] [Related]
4. PDLIM2-mediated termination of transcription factor NF-kappaB activation by intranuclear sequestration and degradation of the p65 subunit.
Tanaka T; Grusby MJ; Kaisho T
Nat Immunol; 2007 Jun; 8(6):584-91. PubMed ID: 17468759
[TBL] [Abstract][Full Text] [Related]
5. PDLIM7 is a novel target of the ubiquitin ligase Nedd4-1 in skeletal muscle.
D'Cruz R; Plant PJ; Pablo LA; Lin S; Chackowicz J; Correa J; Bain J; Batt J
Biochem J; 2016 Feb; 473(3):267-76. PubMed ID: 26556890
[TBL] [Abstract][Full Text] [Related]
6. PDLIM2 protects articular chondrocytes from lipopolysaccharide-induced apoptosis, degeneration and inflammatory injury through down-regulation of nuclear factor (NF)-κB signaling.
Guo Q; Xu J; Shi Q; Wu S
Int Immunopharmacol; 2020 Nov; 88():106883. PubMed ID: 32805696
[TBL] [Abstract][Full Text] [Related]
7. PDLIM1 inhibits NF-κB-mediated inflammatory signaling by sequestering the p65 subunit of NF-κB in the cytoplasm.
Ono R; Kaisho T; Tanaka T
Sci Rep; 2015 Dec; 5():18327. PubMed ID: 26679095
[TBL] [Abstract][Full Text] [Related]
8. Inactivation of the putative ubiquitin-E3 ligase PDLIM2 in classical Hodgkin and anaplastic large cell lymphoma.
Wurster KD; Hummel F; Richter J; Giefing M; Hartmann S; Hansmann ML; Kreher S; Köchert K; Krappmann D; Klapper W; Hummel M; Wenzel SS; Lenz G; Janz M; Dörken B; Siebert R; Mathas S
Leukemia; 2017 Mar; 31(3):602-613. PubMed ID: 27538486
[TBL] [Abstract][Full Text] [Related]
9. PDLIM2 inhibits T helper 17 cell development and granulomatous inflammation through degradation of STAT3.
Tanaka T; Yamamoto Y; Muromoto R; Ikeda O; Sekine Y; Grusby MJ; Kaisho T; Matsuda T
Sci Signal; 2011 Dec; 4(202):ra85. PubMed ID: 22155789
[TBL] [Abstract][Full Text] [Related]
10. CKIP-1 couples Smurf1 ubiquitin ligase with Rpt6 subunit of proteasome to promote substrate degradation.
Wang Y; Nie J; Wang Y; Zhang L; Lu K; Xing G; Xie P; He F; Zhang L
EMBO Rep; 2012 Nov; 13(11):1004-11. PubMed ID: 23032291
[TBL] [Abstract][Full Text] [Related]
11. Sequestration of PDLIM2 in the cytoplasm of monocytic/macrophage cells is associated with adhesion and increased nuclear activity of NF-kappaB.
Healy NC; O'Connor R
J Leukoc Biol; 2009 Mar; 85(3):481-90. PubMed ID: 19052146
[TBL] [Abstract][Full Text] [Related]
12. The E3 ubiquitin ligase SCF(Fbxo7) mediates proteasomal degradation of UXT isoform 2 (UXT-V2) to inhibit the NF-κB signaling pathway.
Spagnol V; Oliveira CAB; Randle SJ; Passos PMS; Correia CRSTB; Simaroli NB; Oliveira JS; Mevissen TET; Medeiros AC; Gomes MD; Komander D; Laman H; Teixeira FR
Biochim Biophys Acta Gen Subj; 2021 Jan; 1865(1):129754. PubMed ID: 33010352
[TBL] [Abstract][Full Text] [Related]
13. Klotho ameliorates cyclosporine A-induced nephropathy via PDLIM2/NF-kB p65 signaling pathway.
Jin M; Lv P; Chen G; Wang P; Zuo Z; Ren L; Bi J; Yang CW; Mei X; Han D
Biochem Biophys Res Commun; 2017 Apr; 486(2):451-457. PubMed ID: 28315683
[TBL] [Abstract][Full Text] [Related]
14. Osteopontin and protein kinase C regulate PDLIM2 activation and STAT1 ubiquitination in LPS-treated murine macrophages.
Guo H; Mi Z; Bowles DE; Bhattacharya SD; Kuo PC
J Biol Chem; 2010 Nov; 285(48):37787-96. PubMed ID: 20889505
[TBL] [Abstract][Full Text] [Related]
15. Ubiquitin-associated domain-containing ubiquitin regulatory X (UBX) protein UBXN1 is a negative regulator of nuclear factor κB (NF-κB) signaling.
Wang YB; Tan B; Mu R; Chang Y; Wu M; Tu HQ; Zhang YC; Guo SS; Qin XH; Li T; Li WH; Li AL; Zhang XM; Li HY
J Biol Chem; 2015 Apr; 290(16):10395-405. PubMed ID: 25681446
[TBL] [Abstract][Full Text] [Related]
16. The E3 ubiquitin ligase MIB2 enhances inflammation by degrading the deubiquitinating enzyme CYLD.
Uematsu A; Kido K; Takahashi H; Takahashi C; Yanagihara Y; Saeki N; Yoshida S; Maekawa M; Honda M; Kai T; Shimizu K; Higashiyama S; Imai Y; Tokunaga F; Sawasaki T
J Biol Chem; 2019 Sep; 294(38):14135-14148. PubMed ID: 31366726
[TBL] [Abstract][Full Text] [Related]
17. PDLIM2 acts as a cancer suppressor gene in non-small cell lung cancer via the down regulation of NF-κB signaling.
Shi H; Ji Y; Li W; Zhong Y; Ming Z
Mol Cell Probes; 2020 Oct; 53():101628. PubMed ID: 32621848
[TBL] [Abstract][Full Text] [Related]
18. Suppression of NF-κB activation by PDLIM2 restrains hepatic lipogenesis and inflammation in high fat diet induced mice.
Hao YR; Tang FJ; Zhang X; Wang H
Biochem Biophys Res Commun; 2018 Sep; 503(2):564-571. PubMed ID: 29852170
[TBL] [Abstract][Full Text] [Related]
19. The sequestosome 1/p62 attenuates cytokine gene expression in activated macrophages by inhibiting IFN regulatory factor 8 and TNF receptor-associated factor 6/NF-kappaB activity.
Kim JY; Ozato K
J Immunol; 2009 Feb; 182(4):2131-40. PubMed ID: 19201866
[TBL] [Abstract][Full Text] [Related]
20. USP18 negatively regulates NF-κB signaling by targeting TAK1 and NEMO for deubiquitination through distinct mechanisms.
Yang Z; Xian H; Hu J; Tian S; Qin Y; Wang RF; Cui J
Sci Rep; 2015 Aug; 5():12738. PubMed ID: 26240016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
